Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Tachykinin antagonists and their use described by Takeda

May 29, 2002

AUA presentations discuss use of tamsulosin for BPH

May 29, 2002

Nymox prepares IND for NX-1207

May 27, 2002

Potent and selective PDE5 inhibitors claimed by Lilly Icos

May 27, 2002

VML-670 enters phase II program for antidepressant-related sexual dysfunction

May 24, 2002

Novel treatments for male erectile dysfunction

May 17, 2002

Rho kinase as a potential target for erectile dysfunction Rx

May 17, 2002

CYC-202 to be evaluated in glomerulonephritis

May 16, 2002

Data support inhibition of hypocretin system in the treatment of urinary incontinence

May 16, 2002

Phase II trials begin in Europe and U.S. for KW-7158

May 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...